SCHEMBL7811362

SCHEMBL7811362

CC(=O)N(CCc1cccc(OCc2ccccc2)c1)c1ccc(O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 3/20 0.56
LTB4R2 Q9NPC1 3/20 0.56
CYP4F2 P78329 1/20 0.52
CYP4A11 Q02928 1/20 0.52
MAOB P27338 2/20 0.52
BCHE P06276 6/20 0.51
CYP2D6 P10635 1/20 0.51
ALOX5 P09917 2/20 0.50
PTGES O14684 2/20 0.50
LTC4S Q16873 1/20 0.50
TSPO P30536 1/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
THRB P10828 1/20 0.49
PKM P14618 1/20 0.49
RAB9A P51151 1/20 0.49
BLM P54132 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12400619 0.85 LTB4R (0.40) LTB4RLTB4R2CYP4F2CYP4A11MAOB
SCHEMBL5114053 0.82 LTB4R (0.54) LTB4RLTB4R2CYP4F2CYP4A11MAOB
SCHEMBL5104714 0.81 FFAR1 (0.52) LTB4RLTB4R2CYP4F2CYP4A11MAOB
SCHEMBL5518178 0.79 AOC3 (0.54) ALOX5PTGESTSPO
SCHEMBL5116145 0.78 LTB4R (0.53) LTB4RLTB4R2CYP4F2CYP4A11BCHE
SCHEMBL17361052 0.78 LTB4R2 (0.47) LTB4R2KDM4EMEN1ALDH1A1KMT2A
SCHEMBL26986003 0.77 LTB4R (0.74) LTB4RLTB4R2CYP4F2CYP4A11MAOB
SCHEMBL3660617 0.75 FFAR1 (0.66) LTB4RLTB4R2CYP4F2CYP4A11MAOB
SCHEMBL5519402 0.75 ACHE (0.57)
SCHEMBL5106882 0.74 LTB4R (0.58) LTB4RLTB4R2MAOBBCHEALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163225-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2001-12-19 EP disclosed
WO-2000055137-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed